Chemotherapy before surgery for breast cancer
Treatments studied
Part of Cancer, Skin clinical trials.
This trial tests giving chemotherapy before surgery to shrink breast tumors, which may make surgery easier or allow breast-conserving options. It is for adults with invasive breast cancer that has not spread to distant organs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with invasive breast cancer (confirmed by biopsy).
- Your tumor is at a stage where chemotherapy before surgery is needed to shrink it, either for easier removal or to allow breast-conserving surgery.
- You are in good overall health (able to do daily activities) and your blood counts and liver/kidney function are within acceptable ranges.
- You do not have known distant spread of the cancer (metastasis) or significant heart disease.
- If you can become pregnant, you agree to use a non-hormonal birth control method during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving chemotherapy before surgery, guided by the genetic profile of your tumor, can improve outcomes for a specific type of HER2-positive breast cancer. It aims to tailor treatment to each person's cancer biology.
This study tests two chemotherapy drugs, lobaplatin and carboplatin, given before surgery for HER2 positive breast cancer. The goal is to see if they are safe and help shrink the tumor before it is removed.
This trial tests a treatment given before breast surgery to shrink breast cancer and improve outcomes based on your tumor type. Your eligibility depends on tumor size/stage, hormone and HER2 markers, and overall health checks.
This Phase 3 trial compares hormone-based treatment versus chemotherapy given before surgery in people who are premenopausal and have hormone-receptor positive, HER2-negative breast cancer. It looks to see which approach works better to control the cancer before the breast operation.
This study tests combining chemotherapy before surgery with radiation therapy before surgery for locally advanced breast cancer. The goal is to see if this approach can improve outcomes, especially for patients whose tumors didn't shrink enough with initial chemo.
This trial tests a combination of targeted drugs and chemotherapy before surgery for HER2-positive breast cancer. It aims to see if this approach can shrink or eliminate the tumor, making surgery more effective.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.